Page last updated: 2024-11-08

pentylenetetrazole and Brain Damage, Chronic

pentylenetetrazole has been researched along with Brain Damage, Chronic in 8 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deitrick, RE1
Sommer, H1
Iwanowski, L1
Wasilewski, R1
Adler, MW1
Mason, CR1
Cooper, RM1
Fink, M1
Abrams, R1
Bennett, EL1
Rosenzweig, MR1
Chang Wu, SY1
Gordon, AM1

Other Studies

8 other studies available for pentylenetetrazole and Brain Damage, Chronic

ArticleYear
Pentylenetetrazol with nicotinic acid in the management of chronic brain syndrome.
    Journal of the American Geriatrics Society, 1967, Volume: 15, Issue:2

    Topics: Aged; Brain Damage, Chronic; Female; Humans; Male; Nicotinic Acids; Pentylenetetrazole; Psychologica

1967
[Comparative, morphologic examinations of cardiazol and electroconvulsion in animal experiment].
    Psychiatrie, Neurologie und medizinische Psychologie. Beihefte, 1973, Volume: 17-18

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Damage, Chronic; Cats; Electroshock; Ischemic Attack, Tra

1973
[Observations on succinate and lactate dehydrogenase activity following cardiazol convulsions. (A histochemical study with microdensitometrical evaluation)].
    Psychiatrie, Neurologie und medizinische Psychologie. Beihefte, 1973, Volume: 17-18

    Topics: Animals; Brain; Brain Damage, Chronic; Brain Edema; Densitometry; Frontal Lobe; Hippocampus; Hypoxia

1973
Laboratory evaluation of antiepileptic drugs. The use of chronic lesions.
    Epilepsia, 1969, Volume: 10, Issue:2

    Topics: Animals; Brain Damage, Chronic; Central Nervous System Stimulants; Cerebral Cortex; Ethers; Fluorine

1969
A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol.
    Epilepsia, 1972, Volume: 13, Issue:5

    Topics: Animals; Brain Damage, Chronic; Cerebral Cortex; Dose-Response Relationship, Drug; Male; Pentylenete

1972
Answers to questions frequently asked about ECT.
    Seminars in psychiatry, 1972, Volume: 4, Issue:1

    Topics: Age Factors; Anesthesia, Intravenous; Brain Damage, Chronic; Brain Neoplasms; Depression; Electrocon

1972
Excitant and depressant drugs modulate effects of environment on brain weight and cholinesterases.
    Psychopharmacologia, 1973, Dec-20, Volume: 33, Issue:4

    Topics: Acetylcholinesterase; Age Factors; Animals; Brain; Brain Damage, Chronic; Cholinesterases; Dextroamp

1973
Coping on amphetamines.
    The New England journal of medicine, 1970, Feb-05, Volume: 282, Issue:6

    Topics: Amphetamine; Antidepressive Agents; Brain Damage, Chronic; Child; Child Behavior Disorders; Deanol;

1970